Diagnos Inc.
DGNOF
$0.20
$0.00-1.90%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.91% | -21.43% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.91% | -21.43% | |||
| Cost of Revenue | 9.72% | -3.71% | |||
| Gross Profit | -10.16% | 2.79% | |||
| SG&A Expenses | 1.14% | -1.19% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.28% | -2.12% | |||
| Operating Income | -4.35% | 1.76% | |||
| Income Before Tax | -4.64% | 1.07% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -4.64% | 1.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.64% | 1.07% | |||
| EBIT | -4.35% | 1.76% | |||
| EBITDA | -7.63% | 1.88% | |||
| EPS Basic | 8.97% | 1.27% | |||
| Normalized Basic EPS | 10.20% | 0.00% | |||
| EPS Diluted | 8.97% | 1.27% | |||
| Normalized Diluted EPS | 10.20% | 0.00% | |||
| Average Basic Shares Outstanding | 14.81% | 0.39% | |||
| Average Diluted Shares Outstanding | 14.81% | 0.39% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||